EQL Pharma focuses on niche generics, i.e. pharmaceuticals that have little or no competition despite lacking patent protection. The reason for the limited competition is that these drugs often have a small turnover globally, but a relatively larger turnover in a specific geography, such as a country or a region of countries.
Network and Collaboration Partners
EQL is strategically located in Lund with access to all the resources of organizations, companies and people that are provided in the life science cluster called Medicon Valley. The company has built up a strong network of partners both in the cluster and in the rest of Europe and the world. A network that is in constant growth and refinement as new ideas and opportunities take shape.
Strong, Sustainable and Profitable Growth
The company’s goal is strong, but sustainable and profitable, growth. Robust financing and well-thought-out analyzes are behind every investment the company makes both in its pipeline and in the expansion into new markets.
Competent and Experienced Employees
EQL Pharma strives to attract and retain personnel with excellence in all areas relevant to the company. High level of education, solid proven experience and personal commitment characterize the company’s staff today, which creates stability despite strong growth.
